Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 67296-2198

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-2198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Cont-label (Cont Label)

Cont-label (Cont Label)
This is a product label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets containing 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate. The tablets are used for a specific purpose and come with instructions on dosage, administration, and storage. The medication guide is provided separately to each patient, and the contact information for inquiries is given. The tablets are manufactured for Camber Pharmaceuticals, Inc., by Hetero Labs Limited in India.*
FDA Label Image

Structure-1 (Structure 1)

FDA Label Image

Structure-2 (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.